Literature DB >> 28660474

Ahead of Our Time: Collaboration in Modeling Then and Now.

Renée J G Arnold1, Sean Ekins2.   

Abstract

Mesh：

Year:  2017        PMID： 28660474     DOI： 10.1007/s40273-017-0532-2

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  9 in total

1.  Time for cooperation in health economics among the modelling community.

Authors:  Renée J G Arnold; Sean Ekins
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

2.  Advantages of a Truly Open-Access Data-Sharing Model.

Authors:  Monica M Bertagnolli; Oliver Sartor; Bruce A Chabner; Mace L Rothenberg; Sean Khozin; Charles Hugh-Jones; David M Reese; Martin J Murphy
Journal:  N Engl J Med       Date:  2017-03-23       Impact factor: 91.245

Review 3.  Verification of Decision-Analytic Models for Health Economic Evaluations: An Overview.

Authors:  Erik J Dasbach; Elamin H Elbasha
Journal:  Pharmacoeconomics       Date:  2017-07       Impact factor: 4.981

4.  Data-Sharing Models

Authors:  John G Sotos; Yentram Huyen; Alice Borrelli
Journal:  N Engl J Med       Date:  2017-06-08       Impact factor: 91.245

5.  Data-Sharing Models

Authors:  J Brian Byrd; Casey S Greene
Journal:  N Engl J Med       Date:  2017-06-08       Impact factor: 91.245

6.  Sharing is Caring: The Case for Company-Level Collaboration in Pharmacoeconomic Modelling.

Authors:  Anthony J Hatswell; Fleur Chandler
Journal:  Pharmacoeconomics       Date:  2017-08       Impact factor: 4.981

7.  Model Validation: Has it's Time Come?

Authors:  Jonathan Karnon
Journal:  Pharmacoeconomics       Date:  2016-09       Impact factor: 4.981

Review 8.  The Next Era: Deep Learning in Pharmaceutical Research.

Authors:  Sean Ekins
Journal:  Pharm Res       Date:  2016-09-06       Impact factor: 4.200

9.  Benefits, Challenges and Potential Strategies of Open Source Health Economic Models.

Authors:  William C N Dunlop; Nicola Mason; James Kenworthy; Ron L Akehurst
Journal:  Pharmacoeconomics       Date:  2017-01       Impact factor: 4.981
  9 in total
  3 in total

Review 1.  Transparency in Decision Modelling: What, Why, Who and How?

Authors:  Christopher James Sampson; Renée Arnold; Stirling Bryan; Philip Clarke; Sean Ekins; Anthony Hatswell; Neil Hawkins; Sue Langham; Deborah Marshall; Mohsen Sadatsafavi; Will Sullivan; Edward C F Wilson; Tim Wrightson
Journal:  Pharmacoeconomics       Date:  2019-11       Impact factor: 4.981

2.  The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood.

Authors:  Seamus Kent; Frauke Becker; Talitha Feenstra; An Tran-Duy; Iryna Schlackow; Michelle Tew; Ping Zhang; Wen Ye; Shi Lizheng; William Herman; Phil McEwan; Wendelin Schramm; Alastair Gray; Jose Leal; Mark Lamotte; Michael Willis; Andrew J Palmer; Philip Clarke
Journal:  Pharmacoeconomics       Date:  2019-11       Impact factor: 4.981

3.  Development of a pharmacoeconomic registry: an example using hormonal contraceptives.

Authors:  Annesha White; Meenakshi Srinivasan; La Marcus Wingate; Samuel Peasah; Marc Fleming
Journal:  Health Econ Rev       Date:  2021-03-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.